“Measure what is measurable, and make measurable what is not so”
Galileo Galilei
References
Folse R, Braunwald E (1962) Determination of fraction of left ventricular volume ejected per beat and of ventricular end-diastolic and residual volumes. Experimental and clinical observations with a precordial dilution technic. Circulation 25:674–685
Al-Khatib SM et al (2014) Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA 311:2209–2215
Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200m
Packer M et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355
Marwick TH (2018) Ejection fraction pros and cons: JACC state-of-the-art review. J Am Coll Cardiol 72:2360–2379
Hsu JJ, Ziaeian B, Fonarow GC (2017) Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions. JACC Heart Fail 5:763–771
Petersen LC et al (2021) Survival of patients with acute heart failure and mid-range ejection fraction in a developing country—a cohort study in South Brazil. Arq Bras Cardiol 116:14–23
Pickett CA, Cheezum MK, Kassop D, Villines TC, Hulten EA (2015) Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis. Eur Heart J Cardiovasc Imaging 16:848–852
Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 13:18–28
Shah AM et al (2015) Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 132:402–414
Rodrigues JCL et al (2016) The relationship between left ventricular wall thickness, myocardial shortening, and ejection fraction in hypertensive heart disease: insights from cardiac magnetic resonance imaging. J Clin Hypertens 18:1119–1127
Rodrigues JCL et al (2021) The corrected left ventricular ejection fraction : a potential new measure of ventricular function. Int J Cardiovasc Imaging 1:1–10
Shah SJ et al (2016) Phenotype-specific treatment of heart failure with preserved ejection fraction. Circulation 134:73–90
Gray M (2017) Value based healthcare. BMJ 356:1–2
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mesquita, C.T. Left ventricular ejection fraction: how to improve an established index?. Int J Cardiovasc Imaging 37, 2533–2534 (2021). https://doi.org/10.1007/s10554-021-02199-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-021-02199-y